These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15471379)
1. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. de Seze J; Chapelotte M; Delalande S; Ferriby D; Stojkovic T; Vermersch P Mult Scler; 2004 Oct; 10(5):596-7. PubMed ID: 15471379 [TBL] [Abstract][Full Text] [Related]
2. The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis. Brandt-Wouters E; Gerlach OH; Hupperts RM Int J Gynaecol Obstet; 2016 Aug; 134(2):194-6. PubMed ID: 27177509 [TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. Achiron A; Kishner I; Dolev M; Stern Y; Dulitzky M; Schiff E; Achiron R J Neurol; 2004 Sep; 251(9):1133-7. PubMed ID: 15372259 [TBL] [Abstract][Full Text] [Related]
5. High dose IVIG in the post partum period for prevention of exacerbations in MS. Haas J Mult Scler; 2000 Oct; 6 Suppl 2():S18-20; discussion S33. PubMed ID: 11188773 [TBL] [Abstract][Full Text] [Related]
6. Corticosteroids in the management of acute multiple sclerosis exacerbations. Smets I; Van Deun L; Bohyn C; van Pesch V; Vanopdenbosch L; Dive D; Bissay V; Dubois B; Acta Neurol Belg; 2017 Sep; 117(3):623-633. PubMed ID: 28391390 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period. Winkelmann A; Rommer PS; Hecker M; Zettl UK CNS Neurosci Ther; 2019 Jan; 25(1):78-85. PubMed ID: 29858532 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study. Achiron A; Rotstein Z; Noy S; Mashiach S; Dulitzky M; Achiron R J Neurol; 1996 Jan; 243(1):25-8. PubMed ID: 8869383 [TBL] [Abstract][Full Text] [Related]
10. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom. Tremlett HL; Luscombe DK; Wiles CM J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950 [TBL] [Abstract][Full Text] [Related]
11. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. Confavreux C; Hutchinson M; Hours MM; Cortinovis-Tourniaire P; Moreau T N Engl J Med; 1998 Jul; 339(5):285-91. PubMed ID: 9682040 [TBL] [Abstract][Full Text] [Related]
12. COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients. Leguy S; Lefort M; Lescot L; Michaud A; Vukusic S; Le Page E; Edan G; Kerbrat A; Lebrun-Frenay C; De Sèze J; Laplaud DA; Wiertlewski S; Leray E; Michel L J Neurol; 2022 Oct; 269(10):5571-5581. PubMed ID: 35737108 [TBL] [Abstract][Full Text] [Related]
13. First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis. Neuteboom RF; Verbraak E; Voerman JS; van Meurs M; Steegers EA; de Groot CJ; Laman JD; Hintzen RQ Mult Scler; 2009 Nov; 15(11):1356-8. PubMed ID: 19797262 [TBL] [Abstract][Full Text] [Related]
14. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Vukusic S; Hutchinson M; Hours M; Moreau T; Cortinovis-Tourniaire P; Adeleine P; Confavreux C; Brain; 2004 Jun; 127(Pt 6):1353-60. PubMed ID: 15130950 [TBL] [Abstract][Full Text] [Related]